First Trust Advisors LP lowered its position in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) by 0.1% during the second quarter, Holdings Channel reports. The firm owned 5,848,584 shares of the software maker’s stock after selling 7,360 shares during the period. First Trust Advisors LP’s holdings in Allscripts Healthcare Solutions were worth $74,628,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the company. Arizona State Retirement System boosted its stake in Allscripts Healthcare Solutions by 1.9% in the second quarter. Arizona State Retirement System now owns 76,500 shares of the software maker’s stock worth $976,000 after buying an additional 1,400 shares during the period. Foundry Partners LLC boosted its stake in Allscripts Healthcare Solutions by 34.9% in the second quarter. Foundry Partners LLC now owns 39,693 shares of the software maker’s stock worth $506,000 after buying an additional 10,275 shares during the period. Boston Partners boosted its stake in Allscripts Healthcare Solutions by 16.5% in the second quarter. Boston Partners now owns 5,415,576 shares of the software maker’s stock worth $69,102,000 after buying an additional 767,249 shares during the period. Mesirow Financial Investment Management Equity Management purchased a new stake in Allscripts Healthcare Solutions during the second quarter worth approximately $18,797,000. Finally, Retirement Systems of Alabama boosted its stake in Allscripts Healthcare Solutions by 0.3% in the second quarter. Retirement Systems of Alabama now owns 339,736 shares of the software maker’s stock worth $4,335,000 after buying an additional 893 shares during the period.

Allscripts Healthcare Solutions Inc (NASDAQ MDRX) opened at 12.67 on Friday. The firm’s market cap is $2.29 billion. Allscripts Healthcare Solutions Inc has a 12 month low of $9.80 and a 12 month high of $13.70. The company has a 50-day moving average price of $12.50 and a 200 day moving average price of $12.16.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its quarterly earnings data on Thursday, August 3rd. The software maker reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.15 by $0.04. The business had revenue of $426.10 million for the quarter, compared to analyst estimates of $424.94 million. Allscripts Healthcare Solutions had a negative return on equity of 54.26% and a negative net margin of 33.56%. Allscripts Healthcare Solutions’s revenue was up 10.2% compared to the same quarter last year. During the same quarter last year, the company earned $0.14 EPS. Equities research analysts anticipate that Allscripts Healthcare Solutions Inc will post $0.62 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This report was first reported by Watch List News and is the property of of Watch List News. If you are accessing this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this report can be accessed at https://www.watchlistnews.com/allscripts-healthcare-solutions-inc-nasdaqmdrx-shares-sold-by-first-trust-advisors-lp/1477925.html.

A number of analysts have recently commented on the company. Zacks Investment Research upgraded Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research report on Wednesday. Citigroup Inc. lifted their target price on Allscripts Healthcare Solutions from $13.00 to $14.00 and gave the stock a “neutral” rating in a research report on Monday, August 7th. Morgan Stanley lifted their target price on Allscripts Healthcare Solutions from $11.00 to $12.00 and gave the stock an “underweight” rating in a research report on Monday, August 7th. Maxim Group reiterated a “buy” rating and set a $16.00 target price on shares of Allscripts Healthcare Solutions in a research report on Friday, August 4th. Finally, Piper Jaffray Companies reiterated a “hold” rating and set a $14.00 target price on shares of Allscripts Healthcare Solutions in a research report on Friday, July 21st. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and nine have issued a buy rating to the stock. Allscripts Healthcare Solutions currently has a consensus rating of “Hold” and an average price target of $14.66.

In related news, President Richard J. Poulton sold 25,000 shares of the stock in a transaction dated Tuesday, May 16th. The shares were sold at an average price of $12.06, for a total transaction of $301,500.00. Following the sale, the president now owns 412,488 shares in the company, valued at $4,974,605.28. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.75% of the stock is owned by corporate insiders.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions Inc (NASDAQ:MDRX).

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.